NCT03580473View on ClinicalTrials.gov

Efficacy and Safety of Saturno IIB Association on the Control of Ocular Inflammation Post-phacoemulsification

PHASE2CompletedINTERVENTIONAL
Enrollment

118

Participants

Timeline

Start Date

February 27, 2020

Primary Completion Date

November 30, 2021

Study Completion Date

March 1, 2022

Conditions
Ocular InflammationCataract
Interventions
DRUG

SATURNO II association

opthalmic solution, 4 times a day

DRUG

Vigadexa®

opthalmic solution, 4 times a day

Trial Locations (1)

13.084-791

Allegisa, Campinas

Sponsors

Lead Sponsor

EMS
All Listed Sponsors
lead

EMS

INDUSTRY